Abstract
1 min readJournal Article Why Ca2$ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established Get access P. G. HUGENHOLTZ, P. G. HUGENHOLTZ Thoraxcenter, Erasmus University Hospital RotterdamThe Netherlandsthe Physiologic Institute, Albert Ludwigs UniversitFreiburg, F.R.G. and University of MelbourneHeidelberg, Australia Correspondence should be addressed to Prof. P. G. Hugenholtz Search for other works by this author on: Oxford Academic PubMed Google Scholar P. W. SERRUYS, P. W. SERRUYS Thoraxcenter, Erasmus University Hospital RotterdamThe Netherlandsthe Physiologic Institute, Albert Ludwigs UniversitFreiburg, F.R.G. and University of MelbourneHeidelberg, Australia Search for other works by this author on: Oxford Academic PubMed Google Scholar A. FLECKENSTEIN, A. FLECKENSTEIN Thoraxcenter, Erasmus University Hospital RotterdamThe Netherlandsthe Physiologic Institute, Albert Ludwigs UniversitFreiburg, F.R.G. and University of MelbourneHeidelberg, Australia Search for other works by this author on: Oxford Academic PubMed Google Scholar W. NAYLER W. NAYLER Thoraxcenter, Erasmus University Hospital RotterdamThe Netherlandsthe Physiologic Institute, Albert Ludwigs UniversitFreiburg, F.R.G. and University of MelbourneHeidelberg, Australia Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, Volume 7, Issue 4, April 1986, Pages 270–278, https://doi.org/10.1093/oxfordjournals.eurheartj.a062064 Published: 01 April 1986 Article history Received: 10 July 1985 Revision received: 07 October 1985 Published: 01 April 1986
Discussion(0)
No comments yet. Be the first to comment.